From October 1, 2023 to December 31, 2023, the company has repurchased 777,528 shares, representing 0.23% for CNY 82.13 million. With this, the company has completed the repurchase of 1,089,486 shares, representing 0.32% for CNY 117.15 million under the buyback announced on September 27, 2023.
Shanghai Haohai Biological Technology Co., Ltd.
Equities
6826
CNE100001W69
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.35 HKD | +0.94% |
|
-0.92% | +12.38% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.38% | 1.71B | |
-4.36% | 179B | |
-2.67% | 100B | |
-7.29% | 46.16B | |
+18.16% | 44.81B | |
+9.68% | 44.38B | |
+13.64% | 29.53B | |
+22.31% | 25.83B | |
-7.51% | 23.97B | |
+4.07% | 22.5B |
- Stock Market
- Equities
- 6826 Stock
- News Shanghai Haohai Biological Technology Co., Ltd.
- Tranche Update on Shanghai Haohai Biological Technology Co., Ltd.'s Equity Buyback Plan announced on September 27, 2023.